Preventive effects of early immunosuppressive treatment on the development of interstitial lung disease in systemic sclerosis
Arthiha Velauthapillai(Radboud University Nijmegen), Lidia P Ananieva(Association of Rheumatologists of Russia), David Launay(Inserm), Joško Mitrović(University Hospital Dubrava), Florenzo Iannone(University of Bari Aldo Moro), Alexandra Balbir‐Gurman(Technion – Israel Institute of Technology), Michele Iudici, Christina Bergmann(Friedrich-Alexander-Universität Erlangen-Nürnberg), Gabriela Riemekasten(Universitäres Kinderwunschzentrum Lübeck), Carlomaurizio Montecucco(University of Pavia), Ivan Foeldvari(Center for Rheumatology), Gianluca Moroncini(Marche Polytechnic University), Elena Rezuş(Grigore T. Popa University of Medicine and Pharmacy), Przemysław Kotyla(Medical University of Silesia), Bojana Stamenković, Katja Perdan Pirkmajer(Marche Polytechnic University), Paolo Airó(University of Lisbon), Marco Matucci‐Cerinic(Vita-Salute San Raffaele University), C.H.M. van den Ende(Netherlands Institute for Health Services Research), Serena Guiducci(Azienda Ospedaliero-Universitaria Careggi), Jelena Čolić(Universitätsklinikum Tübingen), Simona Rednic(Charité - Universitätsmedizin Berlin), Nicolas Hunzelmann(University Hospital Cologne), Madelon C Vonk(Radboud University Nijmegen), Yannick Allanore(Inserm), Cosimo Bruni(University of Florence), Merle F. R. Bootsma(Radboud University Nijmegen), Luca Idolazzi(University of Verona), L. Garzanova(Association of Rheumatologists of Russia), Dorota Krasowska(Medical University of Lublin), Oliver Distler(University Hospital of Zurich), Francesco Del Galdo(University of Leeds), Patrícia Carreira, Radim Bečvář(Charles University), Maria De Santis(Medical University of Vienna), Elisabetta Zanatta(University of Padua), José António Pereira da Silva(Hospitais da Universidade de Coimbra), László Czirják(University of Pecs), Christopher Denton, Maurizio Cutolo, Murat Inanc, Ulrich A. Walker(University Hospital of Basel), Jörg Henes(University of Tübingen), Leland W.K. Chung(VA Palo Alto Health Care System)
Cited by 4
Related Papers
EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis
|Annals of the Rheumatic Diseases|2013|1.4k
Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2020|786
EULAR evidence-based recommendations for the management of fibromyalgia syndrome
|Annals of the Rheumatic Diseases|2007|751
Treat-to-target in systemic lupus erythematosus: recommendations from an international task force
|Annals of the Rheumatic Diseases|2014|726